Kelly Mitchell
Physician Assistant · Reston, VANPI 1427421411
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 847 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 847 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$2K
- Johnson & Johnson$2K
- Novartis$2K
- UCB, Inc.$1K
- AstraZeneca$884
- plus $5K from 29 others
What the payments were for
- Food & beverage$16,650100%
- Education$830%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 142 | $2,869 |
| Amgen(2 entities) | 118 | $2,390 |
| Johnson & Johnson(3 entities) | 76 | $1,984 |
| Novartis | 77 | $1,765 |
| UCB, Inc. | 97 | $1,457 |
| AstraZeneca(2 entities) | 38 | $884 |
| Mallinckrodt Hospital Products Inc. | 36 | $812 |
| GSK | 35 | $686 |
| Pfizer | 45 | $594 |
| Lilly USA, LLC | 37 | $593 |
| E.r. Squibb & Sons, L.L.C. | 26 | $565 |
| ANI Pharmaceuticals, Inc. | 39 | $536 |
| Radius Health, Inc. | 33 | $512 |
| Aurinia Pharma U.S., Inc. | 13 | $336 |
| Sanofi | 6 | $120 |
| Genentech USA, Inc. | 4 | $80 |
| Pacira Therapeutics, Inc. | 2 | $68 |
| Organon | 3 | $63 |
| Boehringer Ingelheim | 2 | $50 |
| Octapharma USA, Inc. | 2 | $38 |
| Sandoz | 2 | $37 |
| Cumberland Pharmaceuticals, Inc. | 1 | $32 |
| Fresenius Kabi USA, LLC | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Biocon Biologics Inc | 1 | $23 |
| Celltrion USA Inc. | 1 | $23 |
| Invivyd Inc | 1 | $23 |
| Mylan Institutional Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Tersera Therapeutics LLC | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$487
- SIMPONI ARIA$141
How this compares
$16,733 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 26 | $282,708 |
| Humira(Cf)Adalimumab | 11 | $251,650 |
| RinvoqUpadacitinib | 32 | $251,153 |
| Enbrel SureclickEtanercept | 21 | $148,872 |
| Xeljanz XrTofacitinib Citrate | 11 | $63,938 |
| OtezlaApremilast | 12 | $61,567 |
| Hydroxychloroquine Sulfate | 241 | $11,415 |
| MethotrexateMethotrexate Sodium | 222 | $8,121 |
| Leflunomide | 48 | $4,271 |
| Celecoxib | 115 | $3,866 |
| Lidocaine | 11 | $2,120 |
| Prednisone | 260 | $1,810 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $1,796 |
| Duloxetine Hcl | 33 | $1,305 |
| Pregabalin | 23 | $1,268 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf), Rinvoq | $2,869 | $502,80343 claims |
| AmgenOtezla | $2,390 | $61,56712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Reston
- Lindsay TomReston$71K
- Jennifer KallioReston$27K
- Deborah NelsonReston$13K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.